332 related articles for article (PubMed ID: 34903272)
1. Case series: coronavirus disease 2019 infection as a precipitant of atypical hemolytic uremic syndrome: two case reports.
Kurian CJ; French Z; Kukulich P; Lankiewicz M; Ghimire S; Maarouf OH; Rizk S; Rhoades R
J Med Case Rep; 2021 Dec; 15(1):587. PubMed ID: 34903272
[TBL] [Abstract][Full Text] [Related]
2. Postpartum thrombotic microangiopathy revealed as atypical hemolytic uremic syndrome successfully treated with eculizumab: a case report.
Kourouklaris A; Ioannou K; Athanasiou I; Panagidou A; Demetriou K; Zavros M
J Med Case Rep; 2014 Sep; 8():307. PubMed ID: 25219386
[TBL] [Abstract][Full Text] [Related]
3. Atypical hemolytic uremic syndrome: a case report.
Basnayake BMDB; Wazil AWM; Nanayakkara N; Samarakoon SMDK; Senavirathne EMSK; Thangarajah BUEWDR; Karunasena N; Mahanama RMBSS
J Med Case Rep; 2020 Jan; 14(1):11. PubMed ID: 31928535
[TBL] [Abstract][Full Text] [Related]
4. Early Differentiation of Shiga Toxin-Associated Hemolytic Uremic Syndrome in Critically Ill Adults With Thrombotic Microangiopathy Syndromes.
Joseph A; Rafat C; Zafrani L; Mariani-Kurkdjian P; Veyradier A; Hertig A; Rondeau E; Mariotte E; Azoulay E
Crit Care Med; 2018 Sep; 46(9):e904-e911. PubMed ID: 29979220
[TBL] [Abstract][Full Text] [Related]
5. Atypical Hemolytic Uremic Syndrome Presenting as Acute Heart Failure-A Rare Presentation: Diagnosis Supported by Skin Biopsy.
Kichloo A; Chugh SS; Gupta S; Pandav J; Chander P
J Investig Med High Impact Case Rep; 2019; 7():2324709619842905. PubMed ID: 31010328
[TBL] [Abstract][Full Text] [Related]
6. Plasma resistant atypical hemolytic uremic syndrome associated with a CFH mutation treated with eculizumab: a case report.
Sevinc M; Basturk T; Sahutoglu T; Sakaci T; Koc Y; Ahbap E; Akgol C; Kara E; Brocklebank V; Goodship TH; Kavanagh D; Unsal A
J Med Case Rep; 2015 Apr; 9():92. PubMed ID: 25925370
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic and Therapeutic Challenges in Atypical Hemolytic Uremic Syndrome: A Case Report].
Reis S; Ramos D; Cordinhã C; Gomes C
Acta Med Port; 2019 Oct; 32(10):673-675. PubMed ID: 31625881
[TBL] [Abstract][Full Text] [Related]
8. Atypical hemolytic uremic syndrome in first trimester pregnancy successfully treated with eculizumab.
Andries G; Karass M; Yandrapalli S; Linder K; Liu D; Nelson J; Pawar R; Chugh S
Exp Hematol Oncol; 2017; 6():4. PubMed ID: 28101432
[TBL] [Abstract][Full Text] [Related]
9. [A hemolytic episode following COVID-19 in a case with atypical hemolytic uremic syndrome].
Suzuki K; Nagaharu K; Hachiya K; Nishimura K; Matsumoto T; Tawara I
Rinsho Ketsueki; 2022; 63(3):224-228. PubMed ID: 35387937
[TBL] [Abstract][Full Text] [Related]
10. A novel missense mutation in complement factor I predisposes patients to atypical hemolytic uremic syndrome: a case report.
Wei X; Li J; Zhan X; Tu L; Huang H; Wang Y
J Med Case Rep; 2022 Mar; 16(1):101. PubMed ID: 35241161
[TBL] [Abstract][Full Text] [Related]
11. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.
Mannucci PM; Cugno M
Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489
[TBL] [Abstract][Full Text] [Related]
12. Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome - a case report.
Nunius C; Büttner-Herold M; Bertz S; Schiffer M; Buchholz B
BMC Nephrol; 2020 Mar; 21(1):104. PubMed ID: 32204691
[TBL] [Abstract][Full Text] [Related]
13. COVID-19-associated atypical hemolytic uremic syndrome and use of Eculizumab therapy.
Gill J; Hebert CA; Colbert GB
J Nephrol; 2022 Jan; 35(1):317-321. PubMed ID: 34427905
[TBL] [Abstract][Full Text] [Related]
14. A Rare Case of Lupus Nephritis Presenting as Thrombotic Microangiopathy with Diffuse Pseudotubulization Possibly Caused by Atypical Hemolytic Uremic Syndrome.
Ono M; Ohashi N; Namikawa A; Katahashi N; Ishigaki S; Tsuji N; Isobe S; Iwakura T; Sakao Y; Tsuji T; Kato A; Fujigaki Y; Shimizu A; Yasuda H
Intern Med; 2018 Jun; 57(11):1617-1623. PubMed ID: 29434134
[TBL] [Abstract][Full Text] [Related]
15. ATYPICAL HEMOLYTIC UREMIC SYNDROME IN AN ADULT SUCCESSFULLY TREATED WITH ECULIZUMAB.
Chaudoir C; Ong MG; Gu X; Veillon D; Cotelingam J
J La State Med Soc; 2016; 168(1):12-5. PubMed ID: 26986861
[TBL] [Abstract][Full Text] [Related]
16. POSTPARTUM RENAL THROMBOTIC MICROANGIOPATHY: A TURN-BASED DIFFERENTIAL DIAGNOSIS.
Markin L; Shatylovych K
Wiad Lek; 2022; 75(1):128-131. PubMed ID: 35092261
[TBL] [Abstract][Full Text] [Related]
17. [Ocular manifestations of primary thrombotic microangiopathy].
Smirnova TV; Kozlovskaya NL; Sheludchenko VM
Vestn Oftalmol; 2021; 137(5):138-144. PubMed ID: 34726868
[TBL] [Abstract][Full Text] [Related]
18. Long-term Eculizumab Treatment Contributes to Recovery from End-stage Renal Disease Caused by Atypical Hemolytic Uremic Syndrome.
Yamada Y; Abe R; Okano Y; Miyakawa Y
Intern Med; 2017; 56(9):1085-1088. PubMed ID: 28458317
[TBL] [Abstract][Full Text] [Related]
19. Atypical Hemolytic Uremic Syndrome: Beyond Hemolysis and Uremia.
Tsai HM
Am J Med; 2019 Feb; 132(2):161-167. PubMed ID: 30145224
[TBL] [Abstract][Full Text] [Related]
20. Syndromes of Thrombotic Microangiopathy.
Shatzel JJ; Taylor JA
Med Clin North Am; 2017 Mar; 101(2):395-415. PubMed ID: 28189178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
